Lung Neoplasm — Trials

Lung Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,600 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 651 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07699952	First-line Therapy With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor(EGFR-TKI) Combined With Trastuzumab Rezetecan for Advanced Non-small Cell Lung Cancer(NSCLC) Harboring EGFR Mutations Concomitant With Human Epidermal Growth Factor Receptor 2(HER2) Alterations	not yet recruiting	Phase 2	35	Yongsheng WangOTHER	0	Aug 17, 2026	clinicaltrials
NCT07766538	Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait(ALIA)	not yet recruiting	N/A	500	Sulaiman KhadadahOTHER_GOV